// App-Quantinova.ai

: Enhanced Global Disease Assessment with Advanced Imaging and Targeted Myeloma Lesion Biopsy Highlights Spatial Heterogeneity and Detects Residual Disease in Multiple Myeloma

Researchers

Presenter

  • Sabrina L. Browning

Principal Investigators

  • Terri L. Parker

  • Noffar Bar

  • Tara Anderson

  • Madhav Dhodapkar

  • Stuart Seropian

  • Stephanie Halene

  • Mina L Xu

  • Ria Syam

  • Elan Gorshein

  • Autumn DiAdamo

  • Ashita Talsania

  • Wajih Zaheer Kidwai

  • David H. Witt

  • Victor Chang

  • Francesca Montanari

  • Andrew Lischuk

  • Wei Wei

  • Andrew Haims

  • Natalia Neparidze

Medical Centers

  • Smilow Cancer Hospital Care Center-Waterbury, Yale University School of Medicine and Yale Cancer Center, Waterbury, CT

  • Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT

  • Yale-New Haven Hospital and Yale Cancer Center, New Haven, CT

  • Yale University School of Medicine and Yale Cancer Center, New Haven, CT

  • Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT

  • Department of Genetics, Yale University School of Medicine, New Haven, CT

  • Department of Biostatistics, Yale School of Public Health, New Haven, CT

  • Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • carfilzomib Intravenous

Outcome

  • N/A

Study Design

  • Prospective

  • Global

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved